A subpopulation of breast cancer CTCs marked with EpCAM+CD44+CD47+MET+ was enriched with metastasis-initiating capacity and associated with a reduction in overall survival (Table 2) [126]. The gene discussed is CD44; the disease is breast carcinoma.